U.S. Medical Device Import Requirements — Classification, 510(k), UDI, QMSR
The most complicated of the five categories. Premarket pathways differ completely by risk class (Class I/II/III), so classification is the starting point for everything else — get it wrong and every downstream step is wasted effort.
Requirements Specific to This Category
Device Classification (Class I/II/III)
FDA sorts medical devices into three risk classes. ① Class I (low risk — thermometers, bandages, manual wheelchairs; mostly exempt from premarket notification, subject only to General Controls) ② Class II (moderate risk — blood pressure monitors, syringes, pregnancy tests; usually requires a 510(k)) ③ Class III (high risk — pacemakers, artificial heart valves, other life-sustaining or implantable devices; requires a PMA). Classification attaches to the 'Product Code,' not the product category itself, so similar-looking products can carry different codes and classes depending on their intended use and indications. Start by searching a comparable product name in FDA's Product Classification Database.
When Classification Is Unclear — the 513(g) Request
If a database search alone doesn't give you confidence about a product's code or class, you can file a 513(g) Request for Information and ask FDA for an official classification determination. It's a paid process and typically takes several months to get a response, so start it early in new-product planning. Proceeding on a wrong classification (e.g., treating a Class II device as Class I) can, once discovered post-market, be treated as importing and selling an unapproved device, leading to a full recall.
Premarket Pathways — 510(k) / PMA / De Novo
① 510(k) Premarket Notification — demonstrates 'substantial equivalence' to a legally marketed predicate device. Most Class II devices go this route; FDA's target review time is 90 days, but it stretches considerably if additional information (AI) requests come in. ② PMA (Premarket Approval) — the strictest pathway, required for Class III devices, needing clinical data to demonstrate safety and effectiveness; review typically takes over a year. ③ De Novo — for novel low- or moderate-risk devices with no existing predicate; once granted, the device itself becomes a predicate for future similar products. Without this clearance/approval number (a 510(k) number or a PMA number), import is blocked outright — FDA checks for this number at entry.
Establishment Registration + Device Listing (Annual Renewal, With a Fee)
Facilities (including foreign ones) that manufacture, repackage, or relabel devices must register the establishment and list their devices through FURLS (the Unified Registration and Listing System). Registration must be renewed every year between October 1 and December 31, and an annual Establishment Registration User Fee applies — unlike food FFR, this fee has to be paid fresh every year. Failing to renew or pay voids the registration and removes every device at that facility from eligibility to import.
Designate a U.S. Agent
Foreign manufacturing facilities must designate a U.S. Agent as part of establishment registration. It functions as the official point of contact between FDA and the facility and must be able to respond to FDA inspections and inquiries. As with the food category's U.S. Agent, this can't be a name listed as a formality — it has to be a party that's actually reachable and responsive.
UDI Labeling + GUDID Registration
Most devices must carry a Unique Device Identifier (UDI — a machine-readable barcode plus human-readable text) on the label and packaging, and that information must be entered into FDA's GUDID (Global UDI Database). Phased in starting with Class III, the requirement now covers most devices down through Class I. Codes must come from a UDI issuing agency (GS1, HIBCC, etc.), and GUDID records need to be updated any time the label changes.
Quality System — Transitioning From QSR (21 CFR 820) to QMSR (Aligned With ISO 13485)
Medical device quality-system regulation is changing. The existing Quality System Regulation (QSR, 21 CFR Part 820) is being replaced by the Quality Management System Regulation (QMSR), which FDA has aligned with the ISO 13485:2016 international standard; the final rule was published in 2024, and QMSR governs from the compliance date onward. Foreign manufacturers already ISO 13485–certified face a lighter transition burden; those without certification will need to rebuild their quality system to the new standard. Because compliance dates and grace periods can shift, always reconfirm the current status at fda.gov.
Labeling — Instructions for Use (IFU), International Symbols, and Rx/OTC Distinction
Labels and Instructions for Use (IFU) must be provided in English, showing manufacturer and importer information, lot/serial number, UDI, and the indications for use. Using internationally recognized symbols (ISO 15223-1 — manufacture date, expiration date, sterility status, 'caution: consult instructions before use,' etc.) can reduce the burden of multilingual text. Labeling requirements differ based on prescription status (Rx only vs. OTC), and marketing an Rx device as if it were OTC (or vice versa) constitutes misbranding and grounds for detention.
Medical Device Reporting (MDR, 21 CFR 803)
If a manufacturer or importer becomes aware that a device caused or contributed to a death or serious injury, or malfunctioned in a way that could cause death or serious injury if it recurred, they must file a Medical Device Report (MDR) with FDA under 21 CFR Part 803. Manufacturers must report within 30 days (5 days for events requiring remedial action to prevent an unreasonable risk to public health), and importers carry a separate reporting obligation. The label needs a U.S. contact capable of actually fielding these reports.
Entry Review — the PREDICT System and Common Detention Reasons
Medical device shipments, like food, go through FDA's PREDICT risk screening at CBP filing. Common reasons for detention: ① filing without a 510(k)/PMA number ② a manufacturer that hasn't completed establishment registration or device listing ③ missing required label information (manufacturer, UDI, IFU) ④ a manufacturer or product listed on an Import Alert. Sharing your approval number, registration information, and label copy with your customs broker before the shipment arrives is the single biggest lever for avoiding delay.
IVDs, Software as a Medical Device, and Combination Products — Special Considerations
In vitro diagnostics (IVDs — blood glucose meters, pregnancy tests, diagnostic kits, etc.) follow the same 510(k)/PMA framework as other devices, with an added layer of clinical-validity evidence. Software as a Medical Device (SaMD — diagnostic or monitoring apps, etc.) is classified based on its intended use and separately requires cybersecurity documentation. Drug-device combination products (e.g., prefilled injectors, drug-eluting stents) are assigned to CDER (drugs) or CDRH (devices) depending on the Primary Mode of Action, so it's safest to confirm the lead center early via a Request for Designation (RFD).
Requirements Common to All FDA-Regulated Goods
Entry Filing (via CBP/ACE)
Every import shipment is filed with U.S. Customs and Border Protection (CBP) through the ACE/ABI system. FDA-regulated goods are electronically filed with FDA at the same time, and the PREDICT risk-screening system reviews them automatically. This is typically handled by a customs broker.
Confirm the FDA Product Code
FDA assigns every regulated item a unique product code (industry–class–subclass–PIC). An accurate code is required at entry filing; an incorrect one causes review delays and misclassification. Look up or build the code with the FDA Product Code Builder.
Check Import Alerts in Advance — DWPE Risk
Specific countries, manufacturers, or products can appear on an Import Alert and become subject to Detention Without Physical Examination (DWPE) — an automatic hold with no inspection. Alerts come in three tiers: Red List (automatic detention), Yellow List (conditional detention), and Green List (exempted). A single violation can trigger listing, and suppliers rarely disclose it proactively. Search by company name + address + country + product every time before shipping. Once listed, how you respond in the first 24 hours determines whether recovery takes 6 months or several years — waiting it out or sending only export-country paperwork does not work; you need to engage FDA's compliance staff directly through the formal process. Searchable in this tool's 'Live Lookup' tab.
💡 Practical Tips
- Even everyday products like thermometers and blood pressure monitors need their classification and 510(k) status confirmed — similar products can carry different product codes and classes depending on their indications.
- Whether a device emits radiation (e.g., a laser or X-ray source) can pull in additional regulation (see 'Other' below).
- Unlike food, establishment registration comes with an annual fee — don't confuse it with food FFR, which renews free every two years.
- Quality-system rules are in transition from QSR to QMSR (aligned with ISO 13485) — always reconfirm the current compliance date and grace period at fda.gov.
- Sharing your 510(k)/PMA number, establishment registration number, UDI, and label copy with your broker before clearance reduces PREDICT screening delays.
📋 Quick Reference Table
| Class | Risk Level | Representative Examples | Premarket Pathway | Quality System |
|---|---|---|---|---|
| Class I | Low risk | Thermometers, bandages, manual wheelchairs, exam gloves | Mostly exempt (General Controls only) | QSR/QMSR mostly applies (some exemptions) |
| Class II | Moderate risk | Blood pressure monitors, syringes, pregnancy tests, hearing aids | 510(k) — demonstrate substantial equivalence | QSR/QMSR applies |
| Class III | High risk | Pacemakers, artificial heart valves, implantable devices | PMA — premarket approval including clinical data | QSR/QMSR applies (strictest) |
Classification attaches to the 'Product Code,' not the product category. Similar products can carry different classifications depending on indications and intended use — always verify individually against FDA's Product Classification Database. De Novo is a dedicated pathway for novel low/moderate-risk devices with no existing predicate.